Search Results - "Seiz, Pia"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
  2. 2

    Enhancing virus-specific immunity in vivo by combining therapeutic vaccination and PD-L1 blockade in chronic hepadnaviral infection by Liu, Jia, Zhang, Ejuan, Ma, Zhiyong, Wu, Weimin, Kosinska, Anna, Zhang, Xiaoyong, Möller, Inga, Seiz, Pia, Glebe, Dieter, Wang, Baoju, Yang, Dongliang, Lu, Mengji, Roggendorf, Michael

    Published in PLoS pathogens (01-01-2014)
    “…Hepatitis B virus (HBV) persistence is facilitated by exhaustion of CD8 T cells that express the inhibitory receptor programmed cell death-1 (PD-1)…”
    Get full text
    Journal Article
  3. 3

    New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen by Kucinskaite-Kodze, Indre, Pleckaityte, Milda, Bremer, Corinna M., Seiz, Pia L., Zilnyte, Milda, Bulavaite, Aiste, Mickiene, Gitana, Zvirblis, Gintautas, Sasnauskas, Kestutis, Glebe, Dieter, Zvirbliene, Aurelija

    Published in Virus research (04-01-2016)
    “…•Neutralizing MAb HB1 specific to HbsAg “a” determinant was developed and characterized.•The MAb HB1 recognizes a conserved linear HBsAg epitope…”
    Get full text
    Journal Article
  4. 4

    Studies of nosocomial outbreaks of hepatitis B in nursing homes in Germany suggest a major role of hepatitis B e antigen expression in disease severity and progression by Seiz, Pia L, Slanina, Heiko, Ziebuhr, John, Gerlich, Wolfram H, Glebe, Dieter, Schüttler, Christian G

    “…Abstract Hepatitis B virus (HBV) causes acute or chronic hepatitis B. Local outbreaks of HBV infections in skilled nursing facilities is a matter of growing…”
    Get full text
    Journal Article
  5. 5

    Entecavir allows an unexpectedly high residual replication of HBV mutants resistant to lamivudine by Geipel, Andreas, Seiz, Pia L, Niekamp, Hauke, Neumann-Fraune, Maria, Zhang, Ke, Kaiser, Rolf, Protzer, Ulrike, Gerlich, Wolfram H, Glebe, Dieter

    Published in Antiviral therapy (01-01-2015)
    “…Entecavir is an efficient inhibitor of HBV reverse transcriptase (RT) and widely used for therapy of chronic hepatitis B. Entecavir treatment of HBV patients…”
    Get more information
    Journal Article
  6. 6

    Characterization of the 3rd International Standard for hepatitis B virus surface antigen (HBsAg) by Seiz, Pia L, Mohr, Christina, Wilkinson, Dianna E, Ziebuhr, John, Schuettler, Christian G, Gerlich, Wolfram H, Glebe, Dieter

    Published in Journal of clinical virology (01-09-2016)
    “…Highlights • Overall the 3rd HBsAg International Standard (IS) is very similar to the 2nd IS. • The 2nd IS with HBV subgenotype A2, HBsAg subtype adw2 was from…”
    Get full text
    Journal Article
  7. 7

    International collaborative study on the 3rd WHO International Standard for hepatitis B surface antigen by Wilkinson, Dianna E, Seiz, Pia L, Schüttler, Christian G, Gerlich, Wolfram H, Glebe, Dieter, Scheiblauer, Heinrich, Nick, Sigrid, Chudy, Michael, Dougall, Thomas, Stone, Lindsay, Heath, Alan B

    Published in Journal of clinical virology (01-09-2016)
    “…Highlights • The WHO International Standard (IS) for hepatitis B surface antigen (HBsAg) is used to standardize HBsAg assays. • A WHO international…”
    Get full text
    Journal Article
  8. 8

    Enhancing Virus-Specific Immunity In Vivo by Combining Therapeutic Vaccination and PD-L1 Blockade in Chronic Hepadnaviral Infection: e1003856 by Liu, Jia, Zhang, Ejuan, Ma, Zhiyong, Wu, Weimin, Kosinska, Anna, Zhang, Xiaoyong, Möller, Inga, Seiz, Pia, Glebe, Dieter, Wang, Baoju, Yang, Dongliang, Lu, Mengji, Roggendorf, Michael

    Published in PLoS pathogens (01-01-2014)
    “…Hepatitis B virus (HBV) persistence is facilitated by exhaustion of CD8 T cells that express the inhibitory receptor programmed cell death-1 (PD-1)…”
    Get full text
    Journal Article
  9. 9